default author photo

M. Emmy M. Dolman

Princess Maxima Center for Pediatric Oncology

Utrecht

Netherlands

  • Princess Maxima Center for Pediatric Oncology

SCHOLARLY PAPERS

1

DOWNLOADS

36

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Mek Inhibition Causes BIM Stabilization and Increased Sensitivity to BCL-2 Family Member Inhibitors in RAS-MAPK-Mutated Neuroblastoma

Number of pages: 14 Posted: 26 Jul 2022
Thomas F. Eleveld, Lindy Vernooij, Linda Schild, Bianca Koopmans, Lindy K. Alles, Marli E. Ebus, Rana Dandis, Harm van Tinteren, Huib N. Caron, Jan Koster, M. M. van Noesel, Lieve G.A.M. Tytgat, Selma Eising, Rogier Versteeg, M. Emmy M. Dolman and Jan J. Molenaar
Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, affiliation not provided to SSRN, University of Amsterdam - Department of Oncogenomics, Princess Máxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, Princess Maxima Center for Pediatric Oncology, University of Amsterdam - Department of Oncogenomics, Princess Maxima Center for Pediatric Oncology and Princess Maxima Center for Pediatric Oncology
Downloads 36 (1,236,159)

Abstract:

Loading...

MEK, BCL-2, neuroblastoma, trametinib, navitoclax, venetoclax